Amrut V Ambardekar

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado, Aurora, Colorado Electronic address
    J Heart Lung Transplant 35:722-30. 2016
  2. doi request reprint Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study
    Amrut V Ambardekar
    From the Department of Medicine, Division of Cardiology A V A, Department of Bioengineering K S H, R B D, Department of Pediatrics, Division of Cardiology K S H, Department of Surgery, Division of Cardiothoracic Surgery A N B, Department of Medicine, Divisions of Pulmonary Sciences and Critical Care Medicine R M T, and Department of Surgery, Division of Pediatric Surgery R B D, University of Colorado, Aurora and Vanderbilt Heart and Vascular Institute, Nashville, TN J L
    Circ Heart Fail 8:944-52. 2015
  3. doi request reprint Myocardial strain and strain rate from speckle-tracking echocardiography are unable to differentiate asymptomatic biopsy-proven cellular rejection in the first year after cardiac transplantation
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado, Aurora, Colorado Electronic address
    J Am Soc Echocardiogr 28:478-85. 2015
  4. doi request reprint Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF)
    Amrut V Ambardekar
    Denver Health Medical Center and University of Colorado Denver, Aurora, CO 80045, USA
    Am Heart J 158:644-52. 2009
  5. doi request reprint Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)
    Amrut V Ambardekar
    Division of Cardiology, Denver Health Medical Center, The University of Colorado at Denver and the Health Sciences Center, Denver, Colorado, USA
    Am J Cardiol 105:139-43. 2010
  6. doi request reprint Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device
    Amrut V Ambardekar
    University of Colorado Denver, Aurora, CO 80045, USA
    J Heart Lung Transplant 29:771-6. 2010
  7. doi request reprint Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads
    Amrut V Ambardekar
    Division of Cardiology and Cardiothoracic Surgery, University of Colorado Denver, Aurora, CO 80045, USA
    J Card Fail 16:327-31. 2010
  8. pmc Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado Denver, Aurora, CO 80045, USA
    Circ Heart Fail 4:425-32. 2011
  9. doi request reprint Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure)
    Mori J Krantz
    Denver Health Medical Center and University of Colorado Denver, Denver, Colorado, USA
    Am J Cardiol 107:1818-23. 2011
  10. doi request reprint CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients
    Kimberly M Deininger
    Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Clin Transplant 30:1074-81. 2016

Detail Information

Publications17

  1. pmc High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado, Aurora, Colorado Electronic address
    J Heart Lung Transplant 35:722-30. 2016
    ..We hypothesized that the characteristics defining eligibility for advanced HF therapies would be a primary determinant of outcomes in these patients...
  2. doi request reprint Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous-Flow Left Ventricular Assist Devices: A Pilot Study
    Amrut V Ambardekar
    From the Department of Medicine, Division of Cardiology A V A, Department of Bioengineering K S H, R B D, Department of Pediatrics, Division of Cardiology K S H, Department of Surgery, Division of Cardiothoracic Surgery A N B, Department of Medicine, Divisions of Pulmonary Sciences and Critical Care Medicine R M T, and Department of Surgery, Division of Pediatric Surgery R B D, University of Colorado, Aurora and Vanderbilt Heart and Vascular Institute, Nashville, TN J L
    Circ Heart Fail 8:944-52. 2015
    ..Our aim was to examine the structure of the aorta from patients with continuous-flow left ventricular assist devices (LVADs) and directly measure aortic wall composition and stiffness...
  3. doi request reprint Myocardial strain and strain rate from speckle-tracking echocardiography are unable to differentiate asymptomatic biopsy-proven cellular rejection in the first year after cardiac transplantation
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado, Aurora, Colorado Electronic address
    J Am Soc Echocardiogr 28:478-85. 2015
    ..The aim of this study was to test whether myocardial strain and strain rate as assessed by speckle-tracking echocardiography would be a sensitive noninvasive method for the detection of asymptomatic rejection...
  4. doi request reprint Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF)
    Amrut V Ambardekar
    Denver Health Medical Center and University of Colorado Denver, Aurora, CO 80045, USA
    Am Heart J 158:644-52. 2009
    ..Recognizing features of nonadherent patients may provide a means to reduce rehospitalization for this population...
  5. doi request reprint Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)
    Amrut V Ambardekar
    Division of Cardiology, Denver Health Medical Center, The University of Colorado at Denver and the Health Sciences Center, Denver, Colorado, USA
    Am J Cardiol 105:139-43. 2010
    ..87 to 1.26). In conclusion, within the GWTG-CAD quality improvement initiative, patients with CAD treated at rural hospitals receive similar quality of care and have similar outcomes as those at urban centers...
  6. doi request reprint Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device
    Amrut V Ambardekar
    University of Colorado Denver, Aurora, CO 80045, USA
    J Heart Lung Transplant 29:771-6. 2010
    ..However, the rate of implantable cardioverter-defibrillator (ICD) shocks and the effect of these shocks on outcomes in patients with LVADs remain unknown...
  7. doi request reprint Effect of left ventricular assist device placement on preexisting implantable cardioverter-defibrillator leads
    Amrut V Ambardekar
    Division of Cardiology and Cardiothoracic Surgery, University of Colorado Denver, Aurora, CO 80045, USA
    J Card Fail 16:327-31. 2010
    ..We investigated whether the implantation of a LVAD affects ICD function...
  8. pmc Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado Denver, Aurora, CO 80045, USA
    Circ Heart Fail 4:425-32. 2011
    ..We hypothesized that evaluation of myocyte contractility and biochemistry at the sarcomere level before and after LVAD may explain organ-level changes...
  9. doi request reprint Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure)
    Mori J Krantz
    Denver Health Medical Center and University of Colorado Denver, Denver, Colorado, USA
    Am J Cardiol 107:1818-23. 2011
    ..In conclusion, being admitted on evidence-based medications is the most powerful, independent predictor of discharge use...
  10. doi request reprint CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients
    Kimberly M Deininger
    Department of Pharmaceutical Sciences, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Clin Transplant 30:1074-81. 2016
    ..We sought to determine the singular and combined impact of CYP3A4*22 and CYP3A5*3 variants on tacrolimus drug disposition in adult heart transplant recipients...
  11. pmc Left ventricular assist device effects on metabolic substrates in the failing heart
    Lindsay B Weitzel
    Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
    PLoS ONE 8:e60292. 2013
    ..This study set out to measure cardiac metabolites in non-failing hearts, failing hearts, and hearts post-LVAD support...
  12. pmc Concomitant surgical cryoablation for refractory ventricular tachycardia and left ventricular assist device placement: a dual remedy but a recipe for thrombosis?
    Colleen K McIlvennan
    Division of Cardiology, University of Colorado, School of Medicine, 12631 East 17th Avenue, B130, Aurora, CO, 80045, Canada
    J Cardiothorac Surg 11:53. 2016
    ..Ventricular tachycardia (VT) can persist following placement of a left ventricular assist device (LVAD). The optimal management strategy for VT during the peri-LVAD period is unknown...
  13. ncbi request reprint Chronic Norovirus Infections in Cardiac Transplant Patients: Considerations for Evaluation and Management
    Paul T Jurgens
    School of Medicine, University of Colorado, Aurora, CO, USA
    Prog Transplant . 2016
    ..Although brief discontinuation of immunosuppression is often required to achieve symptom, graft rejection is often a complication...
  14. pmc Patient-centered care for left ventricular assist device therapy: current challenges and future directions
    Khadijah Breathett
    Division of Cardiology, University of Colorado, Aurora, Colorado, USA
    Curr Opin Cardiol 31:313-20. 2016
    ..Discuss the current status and obstacles that need to be overcome in the future to provide patient-centered care with left ventricular assist device (LVAD) therapy...
  15. ncbi request reprint Evaluating Patient-Level Medication Regimen Complexity Over Time in Heart Transplant Recipients
    Brittney M Bryant
    University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
    Ann Pharmacother . 2016
    ..However, a systematic assessment of medication regimen complexity over time has not been conducted in this, or any other, transplant population...
  16. pmc Increased mortality among survivors of myocardial infarction with kidney dysfunction: the contribution of gaps in the use of guideline-based therapies
    Pamela N Peterson
    Denver Health Medical Center, Denver, Colorado, USA
    BMC Cardiovasc Disord 9:29. 2009
    ..We assessed the degree to which differences in guideline-based medical therapy for acute myocardial infarction (AMI) contribute to the higher mortality associated with kidney disease...
  17. ncbi request reprint Case of ventricular noncompaction: the crypts and the blood
    Amrut V Ambardekar
    Division of Cardiology, University of Colorado Health Sciences Center and Denver Health Medical Center, Denver, CO, USA
    Mayo Clin Proc 83:866. 2008